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Abstract
The main virulence factor of Streptococcus pneumoniae is the capsule. The polysaccharides comprising this capsule are
encoded by approximately 15 genes and differences in these genes result in different serotypes. The aim of this study was
to investigate the sequence diversity of the capsular genes of serotypes 6A, 6B, 6C, 19A and 19F and to explore a possible
effect of vaccination on variation and distribution of these serotypes in the Netherlands. The complete capsular gene locus
was sequenced for 25 serogroup 6 and for 20 serogroup 19 isolates. If one or more genes varied in 10 or more base pairs
from the reference sequence, it was designated as a capsular subtype. Allele-specific PCRs and specific gene sequencing of
highly variable capsular genes were performed on 184 serogroup 6 and 195 serogroup 19 isolates to identify capsular
subtypes. This revealed the presence of 6, 3 and a single capsular subtype within serotypes 6A, 6B and 6C, respectively. The
serotype 19A and 19F isolates comprised 3 and 4 capsular subtypes, respectively. For serogroup 6, the genetic background,
as determined by multi locus sequence typing (MLST) and multiple- locus variable number of tandem repeat analysis
(MLVA), seemed to be closely related to the capsular subtypes, but this was less pronounced for serogroup 19 isolates. The
data also suggest shifts in the occurrence of capsular subtypes within serotype 6A and 19A after introduction of the 7-valent
pneumococcal vaccine. The shifts within these non-vaccine serotypes might indicate that these capsular subtypes are filling
the niche of the vaccine serotypes. In conclusion, there is considerable DNA sequence variation of the capsular genes within
pneumococcal serogroup 6 and 19. Such changes may result in altered polysaccharides or in strains that produce more
capsular polysaccharides. Consequently, these altered capsules may be less sensitive for vaccine induced immunity.
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Introduction
Streptococcus pneumoniae, the pneumococcus, is responsible for
infections such as meningitis, pneumonia and otitis media. The main
virulence factor of the pneumococcus is its polysaccharide capsule. It
protects the bacteria against phagocytosis and plays an important role
in colonization of the upper airways [1]. Based on the reaction of the
capsule polysaccharides with antisera, over 90 serotypes are
recognized [2,3,4]. The sugars of the polysaccharides and the linkage
between these sugars differ for each of the serotypes. The genes
encoding the polysaccharides are located within the capsular gene
locus and have a similar arrangement in most serotypes. The locus is
positioned between the genes dexB and aliA [5,6]. At the 59 end, next
to dexB, the genes for regulation and translocation are located. These
genes,designatedwzg,wzh,wzd and wze,arerelativelyconservedinall
serotypes [7]. The genes involved in the synthesis of the
polysaccharide and encoding glycosyltransferases, flippases and
polymerases are located downstream of the regulatory genes. The
wzx encodes flippase which is responsible for the transport of the
sugars across the cytoplasmic membrane. Wzy codes for the
polymerase-activity responsible for the synthesis of the polysaccha-
rides in the so-called wzy-dependent pathway [8,9]. Virtually all
different polysaccharides are synthesized by this pathway except
serotype 3 and 37 polysaccharides which are synthesized by the
synthase-dependent pathway, using the synthase-encoding gene tts
which is located elsewhere on the chromosome [6,10].
Forsome serotypesthesequence ofthecapsularlocuswasalready
available [5,6,11,12] but in 2006 the sequences of the capsular locus
for the known 90 serotypes were published simultaneously [7].
Recently, new serotypes were recognized based on the DNA
sequenceofthegenesinthecapsular locus,forexample serotype 6D
[2]. Nowadays, serogroup 6 consists of serotype 6A, 6B, 6C and 6D.
The difference between serotype 6A and 6B is claimed to be based
on only a single nucleotide in wciP [13]. Two other polymorphisms
inwciPhavebeenfoundtobeassociated withserotype 6Aor6B,but
there is uncertainty whether they are serotype specific [14,15]. The
polysaccharides from serotype 6A and 6B isolates differ in the way
rhamnose is linked to ribitol. The capsular locus of serotype 6C is
similar to serotype 6A, except for wciN which is altered and is 200
base pairs shorter in serotype 6C than in serotype 6A [4]. The
glucose in serotype 6A polysaccharide is substituted by galactose in
serotype 6C [16]. The capsular locus of serotype 6D is similar to
that of serotype 6B but it contains the same altered wciN gene found
in serotype 6C [2].
The capsular gene loci of serogroup 19 were among the first to
be fully investigated [17]. The capsular genes of serotype 19F are
quite similar to those of 19A and also serotype 19B and 19C have
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19A and 19F in the polysaccharides is based on the linkage
between trisaccharides and wzy is thought to account for this
difference in linkage [17,18]. The serotypes 19B and 19C contain
an additional side chain compared to serotypes 19A and 19F and
have additional genes encoding these side chains [17].
In a study to assess the pneumococcal population in the pre-
vaccination era in the Netherlands, capsular sequence typing
(CST) revealed discrepancies between the phenotypic and
genotypic serotyping within serogroup 6 [19]. CST is a molecular
typing method to assess the serotype of a pneumococcal isolate and
is based on a 506 base pairs sequence of the wzh gene. Serotype 6B
and 19F are included in 7-valent pneumococcal conjugate vaccine
(Pfizer Inc., Philadelphia, PA; PCV7), the vaccine that is currently
used in the Netherlands. Epidemiological data show that serotype
19A is increasing in the USA [20] and also in the Netherlands
after implementation of the vaccine in the national immunization
program (unpublished data). This, in combination with the
discrepancies found using CST between the phenotypic and
genotypic serotyping within serogroup 6 prompted us to study
these serotypes to gain insight in the sequence variation of the




Pneumococcal isolates from blood or cerebrospinal fluid in
2004, 2005, 2008 and 2009 were from patients with invasive
pneumococcal disease and collected by the Netherlands Reference
Laboratory for Bacterial Meningitis (NLRBM, Amsterdam, the
Netherlands). Serotyping was performed at the NLRBM using the
Quellung reaction as previously described [21,22]. For molecular
analyses bacteria were grown in 1 ml brain heart infusion broth
with 0.5% yeast-extract overnight at 37uC and 5% CO2. Of each
culture 500 ml was heated for 10 min at 95uC and these lysates
were either used directly or stored at 220uC until use.
For comparison of the number of isolates within capsular
subtypes in the pre- and post-vaccine era, only the strains isolated
by 9 large medical microbiology laboratories, referred to as the
sentinel laboratories, were used. This pneumococcal collection
represents approximately 25% of all cases from Dutch patients
with invasive pneumococcal disease in the Netherlands that
occurred in the years 2004–2005 and 2008–2009.
Sequencing of the complete capsular gene loci
The capsular loci of 25 isolates of serogroup 6 and 20 isolates of
serogroup 19 were sequenced. Primer design was based on
reference sequences [4,7] and performed with Kodon 3.6 software
(Applied Maths, Sint-Martens-Latem, Belgium). The PCR mix-
ture of 20 ml contained Hotstartaq mix (Qiagen, Hilden,
Germany), 10 mM of primer and 2 ml lysate diluted 1:10 in sterile
water. The PCR reaction was 15 min 96uC, 35 cycles of 30 sec
96uC, 1 min 50uC and 3 min 72uC followed by 10 min 72uC and
for products ,1 kb the PCR reaction was the same except 1 min
72uC instead of 3. PCR products were purified with ExosapIt (GE
Healthcare Life Sciences, Chalfont St Giles, U.K.) according to
manufacturer’s protocol. One ml aliquots of the purified PCR
products were used in the sequence reaction on an AB 3730
genetic analyzer using Big Dye Terminator technology (Life
Technologies Corporation, Carlsbad, CA). The sequences of the
complete capsular gene loci are deposited in Genbank (www.ncbi.
nlm.nih.gov/Genbank) with the accession numbers JF911487–
JF911531.
Screening for serogroup 6 and 19 capsular subtypes
If one or more genes varied in 10 or more base pairs from the
reference sequences published by Bentley et al. [7] and Park et al.
[4], the isolate was designated as a capsular subtype. This
threshold of 10 base pairs was arbitrarily chosen to allow for
sufficient differences leading to amino acid substitutions. All
serogroup 6 (n=184), serotype 19A and 19F isolates (n=195) in
our collection were screened using allele-specific PCRs to identify
the capsular subtypes. The allele-specific PCRs for serogroup 6
were created for the variable parts of wzy and rmlC, for serotype
19A for the variable parts of wzg, rmlC, rmlB and rmlD and for
serotype 19F for the variable parts of wzg, wze, wchA and rmlB. For
serogroup 6, the variations within the wzg and rmlA genes were
assessed by sequencing.
Genotyping
Multiple-locus variable number of tandem repeat analysis
(MLVA) was performed as described in detail by Elberse and
Nunes et al. [23]. Briefly, 8 variable number of tandem repeat loci
were amplified in 2 multiplex PCRs in which one of the primers of
each primer pair carried a distinct fluorescent label. The PCR
products were mixed with a fluorescently labeled size standard
(Life Technologies Corporation, Carlsbad, CA) and sized on an
automated sequencer (AB 3730 genetic analyzer). Multi locus
sequence typing (MLST) was performed as previously described
[24,25].
Data Analysis
Alignment of the sequences was performed with Kodon 3.6.
Data analysis and clustering were performed using Bionumerics
version 6.5 (Applied Maths, Sint-Martens-Latem, Belgium).
Tables with the MLVA profiles were imported from the
Genemarker software into Bionumerics and the profiles were
clustered using a categorical similarity coefficient and displayed in
a minimum spanning tree. In a minimum spanning tree circles
indicate the types. The size of the circle indicates the number of
isolates with that particular MLVA type. The lines linking 2 types
in the tree denote variants that differ from each other in a single
VNTR locus (single locus variants). For the minimum spanning
trees all entries from the database were used (n=3592, database
composition on December 20th, 2010) but only the serogroup 6
and 19 isolates were depicted. For assignment of MLVA
complexes, the entire in-house MLVA database (available at
www.mlva.net) was interrogated and the MLVA types with a
single entry were excluded from the complex assignment. MLVA
types belonged to a MLVA complex if their profiles differed in
only a single VNTR locus. MLVA complexes were assigned as
such only if they contained at least 3 MLVA types and a minimum
of 9 entries. The discriminatory ability of the MLVA was
measured using the Simpson’s index of diversity (SID) and 95%
confidence intervals were calculated as proposed before [26,27].
Results
Diversity in the capsular genes of serogroup 6 and 19
The entire capsular locus of 11 serotype 6A isolates was
sequenced and capsular subtypes were identified using the
criterion of 10 or more nucleotide differences in one or more
capsular genes from the reference sequence [4,7]. Six distinct
capsular 6A subtypes could be identified (Fig. 1, designated 6A I–
VI). Major differences were found in wzg and in the rhamnose-
genes, rmlA, rmlC and rmlB. Two isolates had sequences identical to
the reference isolate with the exception of a single nucleotide and
were called capsular subtype 6A-IV. An additional 64 serotype 6A
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specific PCRs and sequencing of the wzg and rmlC genes which led
to another 6 new capsular subtypes (Table 1). The most frequently
found capsular subtypes were 6A-I and 6A-II (23 and 22 isolates,
respectively). The genes with the highest degree of sequence
variation were wzg, rmlA and rmlB. The diversity index of serotype
6A capsular subtypes was 0.799 (0.747–0.850).
The serotype 6B isolates appeared to comprise a more
homogeneous group (diversity index: 0.143 (0.046–0.240) than
serotype 6A (Fig. 1 and Table 1). Ninety-three percent (87 of the
94 serotype 6B isolates) of serotype 6B isolates within our
collection belonged to capsular subtype 6B-I. The main differences
were found within the wzg gene and the rml genes. Remarkably,
virtually all capsular genes in the 3 capsular subtype 6B-III isolates
within the collection differed to a large extent from those in the
reference sequence and from the capsular genes of other serotype
6B capsular subtypes. Screening of the serotype 6B isolates with
allele-specific PCRs and specific gene sequencing resulted in a
single additional new capsular subtype only. Based on the allele-
specific PCRs, capsular subtype 6A-III and 6B-I were indistin-
guishable but according to the sequences of the entire capsular
genes, there was a difference of 19 base pairs between the capsular
subtypes.
The sequences of the complete capsular locus of 3 serotype 6C
isolates were identical. However, the rmlA and rmlB genes in these
isolates differed from those of the reference sequence described by
Park et al. [4]. The screening of the additional 12 serotype 6C
isolates within the collection yielded a single new capsular subtype.
No serotype 6D isolates were found in our collection.
Parts of the rmlA and rmlC genes within serogroup 6 were found
within all capsular subtypes, while other parts of the rmlA and rmlC
genes were specific for a capsular subtype (Fig. 2). This may
indicate that it is a possible recombination site within these genes.
The sequence of wzg of serogroup 6 isolates can be divided into 3
classes. Capsular subtype 6B-III consists of a single wzg class. The
remaining serogroup 6 capsular subtypes could be divided into 2
wzg classes, with 33 base pairs that were specific for each class. It
seemed that a hotspot for mutations was present from base pair
position 951–1116 within this gene. For example, the sequence of
wzg of capsular subtype 6A-III differed from the reference
sequence in 45 base pairs, and 78% (35) of the different base
pairs were found in the mutational hotspot.
Within the sequenced capsular gene clusters of 10 serotype 19A
isolates 3 capsular subtypes were identified (Fig. 3). Screening with
allele-specific PCRs identified no new capsular subtypes within
serotype 19A. Within our collection, 41, 38 and 35 isolates
belonged to capsular subtypes 19A-I, 19A-II and 19A-III,
respectively. The main differences between the capsular subtypes
were found in wzg, rmlC, rmlB and rmlD. The first 363 base pairs of
rmlC of the 19A capsular subtypes were identical to the sequence of
Figure 1. Schematic overview of the capsular gene loci of serogroup 6 isolates. The sequences were compared with the reference
sequences [4,7]. If 10 or more base pairs differed in one or more genes, a new allele number was assigned to the gene. The various alleles are
indicated with colors that differ from the dark blue colors used for the reference genes.
doi:10.1371/journal.pone.0025018.g001
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19A-I and 19A-II appeared to be in the opposite orientation
compared with the rml genes in all other sequenced capsular gene
clusters.
Within the 10 sequenced serotype 19F isolates 4 capsular
subtypes were identified. One capsular subtype, 19F-III, was
rather similar to the reference sequence of Bentley et al. [7].
Screening by allele-specific PCR identified 44, 26, 10 and a single
isolate belonging to capsular subtypes 19F-I, 19F-II, 19F-III and
19F-IV, respectively, but no new capsular subtypes within this
serotype.
Amino acid substitutions in the central region of the
capsular locus of serogroup 6 capsular subtypes
The amino acid substitutions caused by changes in the genes
involved in synthesis and export of the polysaccharides for the
serogroup 6 capsular subtypes are depicted in Fig. 4. Capsular subtype
6B-III was not included in this figure, because of the extensive
differences. Also, the capsular loci of serotype 6C differed significantly
from serotype 6A and 6B isolates in the wciN gene and therefore the
wciN gene for serotype 6C was named wciN6C.W i t h i ns e r o t y p e6 A ,
capsular subtype 6A-II had the most amino acid substitutions and
capsular subtype 6A-IV had no substitutions compared with the
reference sequence. In wchA most non-synonymous substitutions were
found in capsular subtype 6A-I and 6A-V. In the wciN and wciP genes,
a single non-synonymous substitution in 6A capsular subtypes was
identified. The wzy genes of capsular subtypes 6A-II and 6A-VI each
had a 10 nucleotides difference compared with the reference sequence
resulting in 6 amino acid changes.
Among the capsular subtypes of serotype 6B isolates only 4 non-
synonymous substitutions were identified; one in wzy and 3 in wzx.
Capsular subtype 6B-III was substantially different from the other
capsular subtypes (Table 2). In all 6B-III genes involved in
synthesis and export of the polysaccharides there were numerous
non-synonymous substitutions. Most of these changes in amino
acids were identified in wzy and wchA (29 amino acids), both
caused by 34 nucleotide mutations. The lowest number of changes
was found in wciP, and comprised 12 amino acid substitutions.
Three non-synonymous substitutions in wciN were identified in
the serotype 6C isolates compared with the 6C reference sequence
(Fig. 4). Also in wciO, wciP and wzy, 1 to 2 non-synonymous
substitutions were identified. In wzy, all serotype 6C isolates
showed a deletion of 3 residues at position 152 to 154 compared to
serotype 6A and 6B sequences (data not shown).
In wciP, amino acids that distinguish serotype 6A from serotype
6B were found at position 192, 195 and 254 (Table 3). The
serotype 6C isolates were identical in these positions to serotype
6A isolates. In a single serotype 6A isolate a non-synonymous
substitution in position 192 was identified that was not consistent
with the other serotype 6A isolates. This isolate belonged to
capsular subtype 6A-IX, the only isolate identified within this
subtype. The genetic background of this isolate is related to isolates
within the MLVA complex comprising 6A-II and 6C-I isolates.
Amino acid substitutions in the central region of the
capsular loci of serogroup 19 capsular subtypes
The serogroup 19 isolates differed only in a few amino acid
residues from the reference sequences (data not shown). In
capsular subtype 19A-I a single non-synonymous substitution in
wchA, wchP and wzy was identified. In the capsular subtypes 19A-II
and 19A-III there was a single non-synonymous substitution in
wchA and in wzy, but the positions of the substitutions differed
between both capsular subtypes. The wze gene of capsular subtype





n Subtype wzg rmlA wzy rmlC
Serotype 6A (n=75) 23 6A-I 4 (18) 3 (52) 1 1
22 6A-II 5 (14) 2 (64) 2 1
10 6A-III 1 (45) 1 (27) 1 1
7 6A-IV 6 (01) 5 (00) 1 1
4 6A-V 4 (18) 4 (16) 1 1
1 6A-VI 5 (13) 2 (64) 2 2
3 6A-VII
2 1 (53) 7 (65) 1 1
1 6A-VIII
2 5 (14) 1 (27) 2 1
1 6A-IX
2 5 (14) 4 (16) 2 1
1 6A-X
2 9 (18) 3 (52) 1 1
1 6A-XI
2 5 (14) 1 (27) 2 1
1 6A-XII
2 8 (16) 1 (27) 1 1
Serotype 6B (n=94) 87 6B-I 1 (53) 1 (30) 1 1
3 6B-II 7 (17) 4 (40) 1 1
3 6B-III 3 (159) 6 (135) 3 3
1 6B-IV
2 3 (159) 5 (52) 3 1
Serotype 6C (n=15) 12 6C-I 2 (02) 2 (31) 2
3 1
3 6C-II
2 2 (02) 3 (00) 2
3 1
1The various alleles are indicated with different numbers. Base pair difference
compared to the reference sequences [4,7] are indicated between brackets.
2Subtype identified by screening only.
3Differences between the serotype 6C and 6A wzy gene could not be detected
with this PCR.
doi:10.1371/journal.pone.0025018.t001
Figure 2. Mosaic structure indicating possible horizontal
transfer within the rmlA and rmlC genes. Schematic overview of
the rmlA and rmlC genes of serogroup 6 and 19. The various colors
indicate similar sequences within the genes.
doi:10.1371/journal.pone.0025018.g002
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subtypes 19F-I, 19F-II and 19F-IV this gene was 2 amino acids
shorter. Furthermore, capsular subtype 19F-I and 19F-II had 3
non-synonymous substitutions and 19F-IV had 4 non-synonymous
substitutions in this gene compared with the reference sequence.
The wchA gene of capsular subtype 19F-II and 19F-IV differed in
24 non-synonymous amino acid substitutions from the reference
sequence. A few non-synonymous substitutions were identified in
wchO, wchP, wzy and wzx in all of the 19F capsular subtypes.
Genetic background compared with capsular subtypes
MLST and MLVA were performed on the isolates for which the
capsular loci were completely sequenced. Both MLST and MLVA
were performed because MLST is still considered the gold
standard and MLVA can be easily performed on large scale.
The correlation between MLST and capsular subtype was high for
serogroup 6 subtypes, with some exceptions. The MLST profiles
of the capsular subtype 6A-II isolates differed in a single locus (4
base pairs) from each other (Table 4). The MLVA profiles of these
Figure 3. Schematic overview of the capsular gene loci of serogroup 19 isolates. The sequences were compared with the reference
sequences [7]. If 10 or more base pairs differed in one or more genes, a new allele number was assigned to the gene. The various alleles are indicated
with colors that differ from the dark blue (19A) and red (19F) colors used for the reference genes.
doi:10.1371/journal.pone.0025018.g003
Figure 4. Amino acid substitutions in the alleles of the serogroup 6 capsular subtypes. The non-synonymous amino acid substitutions in
the central region of the capsular locus of the serotype 6A, 6B and 6C subtypes are provided compared with the reference sequences [4,7]. Subtype
6B-III was not included in this figure because of the extensive differences. Also, the capsular loci of serotype 6C differed significantly from serotype 6A
and 6B isolates in wciN and therefore the wciN for serotype 6C was depicted as wciN6C.
doi:10.1371/journal.pone.0025018.g004
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amplified, probably because of mutations in the primer sites and
therefore the exact number of repeats is unknown. A single 6B-I
isolate yielded a different MLVA type (MT 528 versus MT 524)
while the ST (ST 176) was identical to other 6B-I isolates (n=4).
The 3 serotype 6C isolates had the same ST but different MTs.
Both the MLST and the MLVA of the serogroup 19 isolates
were highly diverse (Table 4). In the 10 serotype 19A isolates
assessed by MLST, 8 different STs were found and 9 different
MTs. There was no correlation between capsular subtypes and
MLST or MLVA, except for MT67 in the capsular subtype 19A-
III isolates. Also, the genetic background for serotype 19F isolates
was very different, yielding 10 different STs and 9 different MTs
within the 19F isolates. There were 4 new STs within the serotype
19F isolates that were yet unknown in the MLST.net database.
MLVA for all isolates
MLVA was performed for all serogroup 6 and 19 isolates (Fig. 5
and 6, respectively). The isolates within capsular subtype 6A-II
and the serotype 6C-I isolates were closely related based on
MLVA and MLST. Remarkably, capsular subtype 6B-I separated
into 2 large MLVA complexes. The MLVA types within the 2
subtype 6B-I MLVA complexes differed from each other in 4 or
more loci. The sequence of the capsular genes of the 2 MLVA
complexes within the capsular subtype 6B-I isolates differed
mutually in only 2 base pairs, but this did not lead to amino acid
changes.
Despite the high degree of genotypic diversity as assessed by
MLST and MLVA 52% of the serotype 19A isolates belonged to a
single MLVA complex. The majority (84%) of the capsular
subtype 19A-II isolates belonged to this complex. The capsular
subtypes 19A-I and 19A-III were more diverse, because only 24%
and 43% of these capsular subtypes belonged to that single
complex, respectively. The MLVA of the serotype 19F isolates
revealed a higher degree of diversity than the MLVA of 19A
isolates. Of the 70 MLVA types found within the serotype 19F
isolates, only 7 MLVA types were shared by 2 or more 19F
isolates. The other 63 MLVA types included only a single serotype
19F isolate. Within the 19F-I capsular subtype 56% of the isolates
were single locus variants of each other and clearly formed a
group. However, this group did not meet the criteria to form a
MLVA complex. Within the 19F-II capsular subtype, 46% of the
isolates were genetically related based on MLVA. Other 19F
isolates were scattered throughout the MLVA minimum spanning
tree.
Distribution of capsular subtypes before and after the
introduction of the vaccine
In June 2006 PCV7 was introduced in the Netherlands. Shifts in
capsular subtypes within serotypes after the introduction of the
vaccine were observed (Table 5), although numbers were small.
The number of cases caused by capsular subtype 6A-III had
decreased from 7 cases in 2004–2005 to 1 case in 2008–2009. Also
a decrease in capsular subtype 6C-I and an increase in capsular
subtype 6C-II was observed. Remarkably, capsular subtype 19A-I
accounted for 41% of the serotype 19A isolates in our collection in
the pre-vaccination period and only for 24% in the post-
vaccination period. In contrast, capsular subtype 19A-II increased
within the post-vaccination period from 27% to 44%. Although
these findings are noteworthy, the shifts are not statistically
significant. Based on MLVA, there were 4 MLVA groups of
serotype 19 isolates. The largest group contained isolates of
capsular subtypes 19A-I, 19A-II and 19A-III. The capsular
subtype 19A-I isolates, isolated after the introduction of the
vaccine, were not present in this predominant serotype 19A
MLVA complex, but were found throughout the MLVA
minimum spanning tree and within the other 3 serotype 19A
MLVA groups. The number of vaccine serotype 19F isolates
significantly decreased after the introduction of the vaccine, in
contrast with the isolates belonging to vaccine serotype 6B.
Discussion
In this study we investigated the sequence diversity of the
capsular gene loci within the serotypes belonging to serogroup 6
(serotypes 6A, 6B, 6C) and serogroup 19 (serotypes 19A and 19F)
of isolates from the Netherlands. We observed considerable
variations among the capsular genes within serotypes which
enabled us to assign capsular subtypes based on the sequence of
the entire capsular locus. The largest number of capsular subtypes
was found among serotype 6A, but in serotype 6B the highest
degree of sequence variation between capsular subtypes was
found. Capsular subtype 6B-III differed to a large extend from the
6B reference sequence and from the other 6B capsular subtypes.
For both serogroup 6 and serogroup 19 most sequence diversity
was found in wzg and the rml genes. Possible horizontal transfer of
part of the genes was observed in rmlA and rmlC genes.
Furthermore, in capsular subtype 19A-I and 19A-II, rmlD was
oriented in the opposite direction compared with the rest of the
capsular loci. Remarkably, we observed a decline in a serotype 6A
capsular subtype and a switch between the capsular subtypes of
19A just 2 years after the introduction of PCV7 in the Dutch
national immunization program.
The correlation between the genetic background as determined
by MLVA and MLST and the capsular subtypes was high for
serogroup 6. The isolates within a capsular subtype all had
identical or closely related MLVA profiles. Only the isolates within
capsular subtype 6B-I were separated into 2 MLVA complexes.
Mavroidi et al. assigned cps profiles to the wciP, wzy and wzx genes
of the serogroup 6 isolates based upon single nucleotide differences
[13,28]. MLST of these isolates showed considerable diversity and
Table 2. Nucleotide substitutions and amino acid changes in
subtype 6B-III compared with the 6B reference sequence.
wchA wciN wciO wciP wzy wzx
Synonymous substitutions 44 39 36 19 23 45
Non-synonymous substitutions 34 48 33 12 34 30
Number of amino acid
substitutions
29 27 27 12 29 23
doi:10.1371/journal.pone.0025018.t002
Table 3. Serotype specific important residues in the wciP
gene of serogroup 6.
Position amino acid
serotype n 192 195 254
6A 74 GCT (A) AGT (S) AGG (R)
1 ACT (T) AGT (S) AGG (R)
6B 92 TCT (S) AAT (N) GGG (G)
6C 15 GCT (A) AGT (S) AGG (R)
doi:10.1371/journal.pone.0025018.t003
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The serotype 6A and 6B isolates in our study did not show overlap
in MLST or MLVA. We verified whether the capsular subtype
assignment would be different if we would assign the capsular
subtypes in this study based on a difference of only a single base
pair in the wciP, wzy and wzx genes, but the capsular subtype
division of our collection remained unaltered. A possible
explanation for the difference between Mavroidi’s results and
ours may be the large diversity in source of isolation and
geographic origin of the isolates of Mavroidi et al. whereas we used
only pneumococcal isolates isolated from patients with invasive
disease within the Netherlands.
We identified 3 isolates of capsular subtype 6B-III in which the
genes of the entire capsular locus differed by 943 base pairs (6%)
from the serotype 6B reference sequence, resulting in 282 (5%)
amino acid changes. In the genes involved in biosynthesis, 397
(5%) base pairs differed from the reference sequence, resulting in
147 (6%) amino acids changes. BLAST results revealed that this
sequence was similar to an unpublished GenBank entry
(AF246897). Also, this sequence is similar to a sequence designated
Table 4. Sequence types and MLVA types of the capsular subtypes.
MLST MLVA (BOX loci)
Serotype Subtype n ST aroe gdh gki recP spi xpt ddl MT 1 2 3 4 6 11 12 13
6 A 6 A - I 2 6 8 1 2 5 91 61 91 4 5 7 8 43 1 2 52 115
6A-II 1 327 1 5 7 12 10 1 14 697 5 3 99 99 2 1 1 6
6A-II 1 3218 1 5 7 12 10 1 8 742 6 3 5 3 2 1 1 6
6A-III 2 207 10 8 30 5 6 1 9 667 5 3 2 4 1 99 3 1
6A-IV 2 65 2 7 4 10 10 1 27 66 1 2 7 3 3 1 4 3
6 A - V 2 1 1 4 3 7 2 5 41 1 5 1 2 8 3 9 2 32 743 262
6A-VI 1 327 1 5 7 12 10 1 14 691 5 3 12 99 2 1 1 6
6 B 6 B - I 2 1 3 8 7 5 85 1 0 6 1 4 2 4 5 23 223 275
6 B - I 4 1 7 6 7 1 3 86 1 0 6 1 4 5 2 4 42 232 266
6 B - I 1 1 7 6 7 1 3 86 1 0 6 1 4 5 2 8 42 232 29 9 6
6B-II 1 497 7 25 4 2 48 20 28 406 3 2 12 4 0 1 7 2
6 B - I I 1 n e w 1 7 2 5 94 4 8 2 084 0 3 32 943 172
6B-III 1 new2 7 6 1 8 6 1 14 413 3 3 1 3 2 2 1 5
6B-III 1 90 5 6 1 2 6 3 4 775 7 2 6 3 2 2 1 2
6C 6C-I 1 1692 1 5 7 12 17 158 14 651 5 2 11 99 2 1 1 7
6C-I 1 1692 1 5 7 12 17 158 14 870 5 3 99 3 2 1 1 6
6C-I 1 1692 1 5 7 12 17 158 14 653 5 2 12 3 2 1 1 6
1 9 A 1 9 A - I 1 1 5 2 1 1 04 3 41 64 86 9 12 742 255
19A-I 1 193 8 10 2 16 1 26 1 846 99 2 9 2 1 1 1 6
19A-I 1 416 1 13 14 4 17 51 14 68 1 2 7 4 2 2 5 3
1 9 A - I 1 4 2 3 1 5 41 2 53 87 1 12 742 265
19A-I 1 199 8 13 14 4 17 4 14 535 4 2 6 1 1 99 2 1
19A-I 1 1045 7 14 4 12 1 14 14 634 5 2 3 5 2 1 10 1
1 9 A - I 1 1 7 9 7 1 4 4 0 1 2 11 1 4 4 5 0 33 863 233
19A-II 1 199 8 13 14 4 17 4 14 80 1 2 8 4 2 1 5 3
19A-III 1 309 8 10 2 5 9 48 6 67 1 2 7 4 2 1 5 3
19A-III 1 416 1 13 14 4 17 51 14 67 1 2 7 4 2 1 5 3
19F 19F-I 1 3008 1 5 14 4 17 51 14 296 2 3 10 99 2 2 9 1
19F-I 1 1045 7 14 40 12 1 1 14 804 7 3 12 99 2 2 7 1
19F-I 1 200 8 13 14 4 1 4 14 295 2 3 10 99 2 2 7 1
19F-I 1 new3 5 5 62 5 9 3 19 434 3 3 5 3 2 1 12 2
19F-II 1 172 7 13 8 6 25 6 8 68 1 2 7 4 2 2 5 3
19F-II 1 876 8 13 14 4 6 4 14 480 3 4 7 6 0 1 5 3
19F-II 1 new4 10 8 30 35 9 1 9 555 4 2 16 3 2 1 9 5
19F-III 1 new5 2 27 2 4 9 6 31 162 2 2 1 2 2 1 6 1
19F-III 1 new6 1 new 9 12 9 3 19 1005 3 2 6 3 2 1 5 4
19F-IV 1 199 8 13 14 4 17 4 14 68 1 2 7 4 2 2 5 3
99, locus could not be amplified.
doi:10.1371/journal.pone.0025018.t004
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sequence contains almost always an INDEL in wciP and differs in
5.4% from the reference sequence in wciP, wzx and wzy [13,28]. As
virtually all capsular genes differ from other serotype 6B capsular
subtypes, we believe that capsular subtype 6B-III may represent a
different serotype that expresses a capsular polysaccharide which
cross-reacts with the 6B specific antiserum. After serological and
biochemical characterization has confirmed the distinct nature of
this variant it may well become ‘serotype 6E’.
Park et al. suggested that serotype 6C had evolved from a
serotype 6A strain of which wciN was replaced by one of an
unknown origin [4]. However, recently Bratcher et al. refined this
theory and suggested that serotype 6C has evolved independently
from serotype 6A. Serotype 6C would have evolved by the
recombination of a large DNA fragment including both wciN and
wzy from a nasopharyngeal gene pool that has not yet been defined
[28]. However, our data show that the MLST and MLVA profiles
of capsular subtype 6A-II and 6C are closely related and this
would support the theory of Park et al. that serotype 6C is a
descendent of serotype 6A.
According to literature, the difference between the capsule
produced by serotype 6A and 6B strains is caused by a single
nucleotide substitution in wciP at amino acid residue 195 [13],
which was found in more than 100 serotype 6A and 6B isolates.
Another position in wciP, amino acid residue 192, is thought to
differentiate also between serotype 6A and 6B, but the data were
Figure 5. Relationship of the serogroup 6 capsular subtypes assessed by MLVA. Minimum spanning tree of the results obtained by MLVA
for the 183 serogroup 6 isolates. Each colored circle indicates a genotype and the colors indicate the different capsular subtypes. Ellipses indicate
capsular subtypes that have related MLVA profiles. The backbone of this minimum spanning tree is created using the entire MLVA database
(n=3592) (December 20, 2010), with only the branches made visible. The grey halos indicate MLVA complexes.
doi:10.1371/journal.pone.0025018.g005
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marked as a serotype specific residue [15]. However, this was
tested in 5 isolates only and again the outcome was inconsistent.
Therefore, Sheppard et al. proposed that these isolates express a
dual serotype due to an incomplete serotype switch. In our study,
we assessed the sequence of wciP in 75 serotype 6A and 92
serotype 6B isolates and found that all 3 amino acid positions (192,
195 and 254) were serotype specific, except for a single 6A isolate
at position 192. The positions 195 and 254 seemed to contain
serotype 6A and 6B specific amino acids and therefore to
distinguish serotype 6A from 6B, these 2 positions could be
targeted for molecular identification. In this case, minimal
sequence differences account for changes in polysaccharides and
serotype. In our study, a threshold of 10 base pair difference in a
gene is used to identify capsular subtypes. Smaller numbers of base
pair differences are disregarded and thereby possibly relevant
changes in the polysaccharides. However, clustering based on the
sequences of the entire capsular loci of serogroup 6 and 19 isolates
revealed the same subdivision compared to our threshold of 10
base pair difference in a gene.
There was a large diversity between the wzg, rmlA and rmlB
genes between the isolates belonging to serogroup 6. Possible sites
for horizontal transfer were observed in the rmlA and rmlC genes. It
seems that within rmlA, there has been frequent transfer of part of
the genes between the serogroup 6 capsular subtypes resulting in a
mosaic structure. It seemed that the rml genes could be an
important site for horizontal transfer, but we found no secondary
mosaic site at the beginning of the capsular locus that could
indicate the other recombination site required for transfer of the
entire capsular gene locus. However, there is a mutational hotspot
in wzg, but the capsular subtypes with the same mutations within
wzg did not correspond with the capsular subtypes yielding the
same rmlA and rmlC genes. Croucher et al. recognized that a
serotype 6A capsular locus was inserted into a PMEN1
Figure 6. Relationship of the serogroup 19 capsular subtypes assessed by MLVA. Minimum spanning tree of the results obtained by MLVA
for the 195 serotype 19A and 19F isolates. Each colored circle indicates a genotype and the colors indicate the different capsular subtypes. Ellipses
indicate capsular subtypes that have related MLVA profiles. The backbone of this minimum spanning tree is created using the entire MLVA database
(December 20, 2010), with only the branches made visible. The grey halos indicate MLVA complexes.
doi:10.1371/journal.pone.0025018.g006
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of the capsular locus and within the rml genes [29]. Because we
sequenced only the capsular genes and not the upstream region,
such sites would not be detected in our study.
Our data showed that the rmlD genes of 79 serotype 19A isolates
were oriented in the opposite direction compared to other
sequenced rml genes, but also compared to the rest of the capsular
genes. This gene arrangement was previously identified by
Morona et al. and the promoter was found to be upstream of
the rmlD gene [17]. Also in Streptococcus mitis and Streptococcus oralis
rmlD is present in the opposite direction [30]. The finding that
69% (79 of 114) of the 19A isolates carried this rmlD gene
suggested that this does not affect polysaccharide production or
invasiveness.
The genetic background of serogroup 19 is known to be highly
diverse [31,32]. In our study, no clear relationship exists between
the capsular subtypes of serogroup 19 and the genetic background.
Five of the 10 STs that were found for serotype 19A isolates within
our study were recognized previously in serotype 19F isolates
according to the www.MLST.net database. This might indicate a
horizontal transfer from serotype 19A capsular genes into a
serotype 19F background. In a study performed by van Gils et al.,
nasopharyngeal colonization of serotype 19A was investigated
using MLST. They found 2 serotype 19A isolates in vaccinated
children with a sequence type previously associated with serotype
19F [33]. Selection of such variants in these studies might have
occurred under pressure of the vaccine.
Noteworthy is the difference in distribution of some capsular
subtypes before and after the introduction of the PCV7 vaccine.
Although the vaccine does not contain serotype 6A, a decrease of
the capsular subtype 6A-III occurred 2–3 years after vaccine
introduction. The sequence of the capsular genes of subtype 6A-III
was remarkably similar to the most prominent serotype 6B
capsular subtype 6B-I which may suggest cross-protection. The
capsular subtype 6A-III isolates used in this study were isolated
from adults only suggesting that perhaps the already induced herd
immunity could account for the decline in frequency of capsular
subtype 6A-III, but we cannot exclude that normal fluctuations in
the pneumococcal population could also account for the
differences. Remarkable, but yet not statistically significant
differences were seen in distribution of the serotype 19A capsular
subtypes frequencies of the pre- and post-vaccine collection. The
data suggest capsular subtype replacement from 19A-I to19A-II
possibly indicating that capsular subtype 19A-II may be more
successful in a human population where children are vaccinated
against serotype 19F. The only difference between the capsular
genes of 19A-I and 19A-II is found in the wzg gene. As wzg is
involved in regulation of capsule production the 19A-II capsular
subtype may have enhanced polysaccharide production. In a study
of Weinberger et al. the serotypes with a higher degree of
Table 5. Capsular subtypes of serogroup 6 and 19 in years pre-and post- vaccine introduction in the Netherlands.
Total 2004–2005 2008–2009
Subtype n n (%) n (%) p value
1
Serotype 6A 6A-I 18 9 (28) 9 (31) 1.000
6A-II 18 11 (34) 7 (24) 0.414
6A-III 8 7 (22) 1 (3) 0.055
6A-IV 7 2 (6) 5 (17) 0.241
6A-V 3 1 (3) 2 (7) 0.600
6A-VI 1 1 (3) 0 (0) 1.000
6A other 6 1 (3) 5 (17) 0.093
Total 6A 61 32 (100) 29 (100) 0.697
serotype 6B 6B-I 73 36 (92) 37 (93) 1.000
6B-II 2 1 (3) 1 (3) 1.000
6B-III 3 2 (5) 1 (3) 0.615
6B other 1 0 (0) 1 (3) 1.000
Total 6B 79 39 (100) 40 (100) 1.000
Serotype 6C 6C-I 12 8 (100) 4 (57) 0.077
6C other 3 0 (0) 3 (43) 0.077
Total 6C 15 8 (100) 7 (100) 0.800
Serotype 19A 19A-I 31 17 (41) 14 (24) 0.079
19A-II 37 11 (27) 26 (44) 0.095
19A-III 32 13 (32) 19 (32) 1.000
Total 19A 100 41 (100) 59 (100) 0.102
Serotype 19F 19F-I 39 26 (63) 13 (54) 0.601
19F-II 18 11 (27) 7 (29) 1.000
19F-III 7 3 (7) 4 (17) 0.409
19F-IV 1 1 (2) 0 (0) 1.000
Total 19F 65 41 (100) 24 (100) 0.033
1Fisher exact test, 2 sided, italic if statistically significant (p,0.05).
doi:10.1371/journal.pone.0025018.t005
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and more prevalent in carriage [34]. Therefore, higher production
levels of the capsule would be advantageous in survival of the
pneumococcus.
In conclusion, our study on the composition of the capsular
genes of serogroup 6 and 19 revealed numerous substitutions
within the serotypes. Changes within the capsular gene loci may
result in altered polysaccharides or in increased production of the
capsule making strains less sensitive for the vaccine induced
immunity. We have isolated the polysaccharides of these
serogroup 6 and 19 variants and are currently investigating the
reactivity of vaccine induced and naturally induced antibodies
with these polysaccharides to elucidate the effect of altered
capsular genes on the structure of the capsule of the pneumococ-
cus.
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